Stay updated on FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page.

Latest updates to the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedNo significant changes were observed in the page content, including study design, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check15 days agoNo Change Detected
- Check36 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference3%

- Check43 days agoChange DetectedAdded new medical topics on bile duct conditions and updated the revision version from v3.0.2 to v3.1.0.SummaryDifference0.7%

- Check58 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The 'Back to Top' link was removed.SummaryDifference0.2%

- Check65 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check72 days agoChange DetectedThe web page has been updated to include new drug information and resources related to specific diseases, while also removing outdated location details and certain genetic disease resources. Notably, the facility name and location have been clarified.SummaryDifference6%

Stay in the know with updates to FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT-2102 in IDH1-Mutant Solid Tumors Clinical Trial page.